View Study [6]"Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic Selank" Medvedev VE, et al., 2012 Finding: Intranasal Selank administered to patients with generalized anxiety disorder (reported up to 2700 mcg/day), with anxiolytic efficacy comparable to benzodiazepines without sedation or withdrawal
Men who cannot tolerate GLP-1 side effects may find cagrilintide more manageable given its lower odds of nausea and vomiting
Developmental Studies of Curcumin NLCs as Safe Alternative in Management of Infectious Childhood Dermatitis
Nakamura J, Oinuma K, Ohtori S, Watanabe A, Shigemura T, Sasho T, Saito M, Suzuki M, Takahashi K, Kishida S
The evidence is limited and methodologically weak